These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26324275)

  • 1. Assessing primary and secondary resistance to clarithromycin and amikacin in infections due to Mycobacterium avium complex.
    Renvoisé A; Brossier F; Galati E; Veziris N; Sougakoff W; Aubry A; Robert J; Cambau E; Jarlier V; Bernard C
    Antimicrob Agents Chemother; 2015 Nov; 59(11):7153-5. PubMed ID: 26324275
    [No Abstract]   [Full Text] [Related]  

  • 2. GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.
    Huh HJ; Kim SY; Shim HJ; Kim DH; Yoo IY; Kang OK; Ki CS; Shin SY; Jhun BW; Shin SJ; Daley CL; Koh WJ; Lee NY
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antimicrobial susceptibility and genotyping of
    Wang SQ; Jiang GL; Wei GM; Huo FM; Dong LL; Zhao LP; Huang HR; Wang GR
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Jul; 41(7):539-543. PubMed ID: 29996350
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of a rapid detection method of clarithromycin resistance genes in Mycobacterium avium complex isolates.
    Inagaki T; Yagi T; Ichikawa K; Nakagawa T; Moriyama M; Uchiya K; Nikai T; Ogawa K
    J Antimicrob Chemother; 2011 Apr; 66(4):722-9. PubMed ID: 21393190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterizations of clarithromycin-resistant Mycobacterium avium clinical isolates.
    Lee SH; Park YK; Kim CK; Kim HJ
    J Clin Lab Anal; 2011; 25(1):33-6. PubMed ID: 21254240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.
    Ferro BE; Meletiadis J; Wattenberg M; de Jong A; van Soolingen D; Mouton JW; van Ingen J
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1097-105. PubMed ID: 26643335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic drug-susceptibility profiles and genetic analysis based on whole-genome sequencing of Mycobacterium avium complex isolates in Thailand.
    Sirichoat A; Kaewprasert O; Hinwan Y; Faksri K
    PLoS One; 2023; 18(11):e0294677. PubMed ID: 37992075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clarithromycin-sensitive and clarithromycin-resistant Mycobacterium avium strains isolated from AIDS patients during therapy regimens including clarithromycin.
    Matsiota-Bernard P; Zinzendorf N; Onody C; Guenounou M
    J Infect; 2000 Jan; 40(1):49-54. PubMed ID: 10762111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of in vitro synergistic effect between clarithromycin or azithromycin in combination with amikacin against Mycobacterium intracellulare.
    Zhang Z; Lu J; Du Y; Xie F; Wang Y; Sun B; Pang Y
    J Glob Antimicrob Resist; 2019 Sep; 18():183-186. PubMed ID: 30953831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of various antibiotics against Mycobacterium avium-intracellulare, measured by their mutant prevention concentration.
    Rodríguez JC; Cebrián L; López M; Ruiz M; Royo G
    Int J Antimicrob Agents; 2005 Mar; 25(3):221-5. PubMed ID: 15737516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postantibiotic effect of amikacin, rifampin, sparfloxacin, clofazimine and clarithromycin against Mycobacterium avium.
    Horgen L; Legrand E; Rastogi N
    Res Microbiol; 1997 Nov; 148(8):673-81. PubMed ID: 9765852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility and molecular characterization of Mycobacterium intracellulare in China.
    Zhao X; Wang Y; Pang Y
    Infect Genet Evol; 2014 Oct; 27():332-8. PubMed ID: 25131955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant difference in drug susceptibility distribution between Mycobacterium avium and Mycobacterium intracellulare.
    Renvoisé A; Bernard C; Veziris N; Galati E; Jarlier V; Robert J
    J Clin Microbiol; 2014 Dec; 52(12):4439-40. PubMed ID: 25274991
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimycobacterial agents differ with respect to their bacteriostatic versus bactericidal activities in relation to time of exposure, mycobacterial growth phase, and their use in combination.
    Bakker-Woudenberg IA; van Vianen W; van Soolingen D; Verbrugh HA; van Agtmael MA
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2387-98. PubMed ID: 15917538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation.
    Carter G; Young LS; Bermudez LE
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4907-10. PubMed ID: 15561879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates.
    Brown-Elliott BA; Iakhiaeva E; Griffith DE; Woods GL; Stout JE; Wolfe CR; Turenne CY; Wallace RJ
    J Clin Microbiol; 2013 Oct; 51(10):3389-94. PubMed ID: 23946523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of clarithromycin-resistance in Mycobacterium avium intracellulare complex.
    Jamal MA; Maeda S; Nakata N; Kai M; Fukuchi K; Kashiwabara Y
    Tuber Lung Dis; 2000; 80(1):1-4. PubMed ID: 10897378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-kill kinetics of slowly growing mycobacteria common in pulmonary disease.
    Ferro BE; van Ingen J; Wattenberg M; van Soolingen D; Mouton JW
    J Antimicrob Chemother; 2015 Oct; 70(10):2838-43. PubMed ID: 26142475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotyping and clarithromycin susceptibility testing of Mycobacterium avium subsp. hominissuis isolated in Tuscany, Italy.
    Genua F; Menichini M; Lari N; Rindi L
    Infect Genet Evol; 2018 Nov; 65():144-149. PubMed ID: 30055327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activities of clarithromycin and azithromycin against clinical isolates of Mycobacterium avium-M. intracellulare.
    Steele-Moore L; Stark K; Holloway WJ
    Antimicrob Agents Chemother; 1999 Jun; 43(6):1530. PubMed ID: 10383373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.